Why Certain Drug Combinations Backfire
Filed under: Uncategorized
For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen’s protective barriers and opens the door for another to deliver the deathblow. According to first author and research fellow in systems biology Tobias Bollenbach, clinical researchers are primarily interested in drugs that together work better than either alone, and so studies tend to focus on explaining some of the mechanisms behind synergistic drug pairings. One class of drugs he investigated interrupts the replication of DNA and the other blocks the manufacture of proteins. When the team added the additional stress of a protein-synthesis inhibiting drug, such as Tetracycline, instead of causing the cells more trouble, the second drug counteracted the overproduction of ribosomes and proteins. As a result, the cells could more easily withstand the assault of the first drug, yet succumbed to the second, completely removing the strong antagonism between the drugs. Kishony recently received a federal stimulus grant to pursue a study that explores the genetic determinants of drug interactions more broadly and investigates whether cells can be synthetically manipulated to change the way drugs interact.
Related posts:
- Discovery Of Easier Way To Synthesize New Drug Candidates Could Have Big Impact On Pharmaceutical Business Now, MIT chemists have designed a new way to attach...
- Link Between Gestational Diabetes, Serotonin And Dietary Protein The cause of diabetes during pregnancy is directly controlled by...
- Cheap Drug - Bevacizumab (Avastin) For Bowel Cancer - Effective For Sight Loss In Elderly People Ranibizumab was not included in this study (it was not...
Related posts brought to you by Yet Another Related Posts Plugin.
Comments
Tell me what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

